Cost-Effectiveness of Icosapent Ethyl for Ischemic Cardiovascular Events
Based on the current study, IPE is cost-effective, with a higher probability of cost-effectiveness in patients undergoing secondary prevention than those in primary prevention.
Authors
- Jalal Arabloo (ORCID: https://orcid.org/0000-0003-1223-4528)
- Hamid Pourasghari (ORCID: https://orcid.org/0000-0002-5148-2869)
- Samad Azari (ORCID: https://orcid.org/0000-0003-2781-7793)
- Masoud Behzadifar (ORCID: https://orcid.org/0000-0002-0271-4360)
- Soheila Rajaie (ORCID: https://orcid.org/0000-0002-0321-7331)
- Masih Tajdini (ORCID: https://orcid.org/0000-0002-5286-9897)
- Mohammad Ali Rezaei (ORCID: https://orcid.org/0009-0006-6257-8096)
- Negar Omidi
Institutions
- Iran University of Medical Sciences (IR)
- Lorestan University of Medical Sciences (IR)
Publication Details
- Journal
- The Journal of Tehran University Heart Center
- Published
- 2025-04-26
- DOI
- https://doi.org/10.18502/jthc.v19is1.18478
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00